Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.30 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.30 |
| ▸ | CHRNG | P07510 | 3/20 | 0.30 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.30 |
| ▸ | CHRND | Q07001 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.30 |
| ▸ | CHRNA2 | Q15822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13861306 | 1.00 | — | — | |
| SCHEMBL26973008 | 1.00 | — | — | |
| Bromide SCHEMBL6847337 | 0.96 | — | — | |
| SCHEMBL31483450 | 0.86 | — | — | |
| SCHEMBL13866433 | 0.84 | — | — | |
| SCHEMBL14671382 | 0.84 | — | — | |
| SCHEMBL22276138 | 0.83 | — | — | |
| SCHEMBL22536323 | 0.83 | — | — | |
| SCHEMBL13601390 | 0.81 | — | — | |
| SCHEMBL12354649 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037641-B2 | Modified nucleotide reagents | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20230366018-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230366018-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| EP-4219506-A1 | PROTECTED DYE-LABELED REAGENTS | Pacific Biosciences Of California, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| US-11578093-B2 | Protected fluorescent reagent compounds | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| US-20220396702-A1 | PROTECTED DYE-LABELED REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| US-11466319-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| EP-3030683-B1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES CALIFORNIA INC (US) | 2022-03-02 | — | — | EP | disclosed |
| WO-2016126941-A1 | MULTIMERIC PROTECTED FLUORESCENT REAGENTS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2016-08-11 | — | — | WO | disclosed |
| US-20150050659-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2015-02-19 | — | — | US | disclosed |
| US-20150050659-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2015-02-19 | — | — | US | disclosed |
| WO-2015021079-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2015-02-12 | — | — | WO | disclosed |
| US-20060189774-A1 | Modifiable polyunsaturated polymers and processes for their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2006-08-24 | — | — | US | disclosed |
| US-6765104-B1 | Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-07-20 | — | — | US | disclosed |
| WO-2001010870-A1 | TRANSITION METAL COMPLEXES OF N,N',N'-TRIALKYL- CIS,CIS-1,3,5-TRIAMINOCYCLOHEXANE AND RELATED COMPOSITIONS AND METHODS OF SYNTHESIS AND USE | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-02-15 | — | — | WO | disclosed |
| EP-0167908-B1 | BRANCHED, THERMOPLASTICALLY PROCESSABLE, IMPACT-RESISTANT POLYAMIDES | BAYER AG (DE) | 1990-04-04 | — | — | EP | disclosed |
| US-4611034-A | POLYETHERAMIDES FROM AN AMMONIA-AMINATED POLYETHER AND A LACTAM; IMPACT STRENGTH; COLD RESISTANCE; MOLDINGS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-09-09 | — | — | US | disclosed |
| EP-0167908-A2 | Branched, thermoplastically processable, impact-resistant polyamides | BAYER AG (DE) | 1986-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150050659-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | ERCC4, ERCC2, ERCC1 | CHRNB2 4219/4885CHRNB4 4446/4885CHRNA3 4704/4885 |
| US-12037641-B2 | Modified nucleotide reagents | POLL, POLN, POLM | CHRNB2 2409/4885CHRNB4 2138/4885CHRNA3 2702/4885 |
| US-20220396702-A1 | PROTECTED DYE-LABELED REAGENTS | POLL, POLB, POLM | CHRNB2 2322/4885CHRNB4 2216/4885CHRNA3 2910/4885 |
| US-11578093-B2 | Protected fluorescent reagent compounds | ERCC4, ERCC2, ERCC1 | CHRNB2 4219/4885CHRNB4 4446/4885CHRNA3 4704/4885 |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | ERCC4, ERCC2, ERCC1 | CHRNB2 4219/4885CHRNB4 4446/4885CHRNA3 4704/4885 |
| US-11466319-B2 | Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing | POLL, POLN, POLB | CHRNB2 1778/4885CHRNB4 1570/4885CHRNA3 1944/4885 |
| US-20230366018-A1 | LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING | POLL, POLN, POLB | CHRNB2 1778/4885CHRNB4 1570/4885CHRNA3 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.